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Relevance to Pathogenesis? 
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Unil!ersity Hospital,· and Childrens Hospital, t and the 
Department ofSurgery,f Pittsburgh, Pennsylvania 
A study to determine the location of dendritic cells, 
in chronic injlam'!latory liver disease was per· 
formed. S 1 00 protein positivity and dendritic cy· 
toplasmic morphology were used to identify den· 
dritic cells. S 100 protein positive dendritic cells 
(S 100 + DC) were found inside the basement memo 
brane between biliary epithelial cells of septal bile 
ducts of livers affected by early stage PBC, but were 
not present at later stages. S 100 + DC also were 
seen in areas of piecemeal necrosis in chronic ac· 
tive hepatitis of various etiologies. In contrast, in· 
tra·epithelial S100 + DC were not found with any 
consistency in sclerosing cholangitis, secondary 
biliary cirrhosis, extrahepatic biliary atresia, or 
chronic liver allograft rejection, all of which are 
characterized by injlammatory bile duct damage. 
The possible relevance of DC in the pathogenesis 
of PBC is discussed. (Am J Pathol 1989, 134: 
741-747) 
A dysregulated cellular immune response is thought to 
be responsible for a number of chronic inflammatory liver 
diseases. 1-5 Although there are many studies of these dis· 
orders based on phenotypic analysis of organ·infiltrating 
inflammatory cells, little is actually known about the immu· 
nopathologic mechanisms responsible for hepatic dam· 
age.s Most investigators have focused on T and B Iym· 
phocytes and their subsets, macrophages and other Iym-
phocytes. More recently, studies have looked at major 
histocompatibility (MHC) antigen expression by paren-
chymal cells. To date, however, we are aware of only one 
study investigating the localization of antigen presenting 
cells (APC) from the dendritic cell lineage in chronic liver 
disease.6 
Dendritic cells (DC) are the most efficient accessory 
cells known J - 13 They are potent stimulators of the mixed 
lymphocytes reaction,7.9.10 playa critical role in the devel-
opment of delayed-type hypersensitivity responses,14 
and are required for initial activation of unprimed T Iym-
phocytes. ll Therefore, DC playa critical role in the gener-
ation of an immune response, particularly during the 
afferent phase. The following study was performed in an 
attempt to begin to understand the role, if any, of DC in 
chronic inflammatory liver diseases by determining their 
location in such disorders. 
Materials and Methods 
Case Selection and Light Microscopy 
A number of chronic inflammatory hepatic diseases were 
selected for study (Table 1). Individual cases were chosen 
from hepatic resection specimens obtained at the time 
of transplantation in an attempt to represent a temporal 
spectrum, as much as possible, of each particular dis-
ease. The diagnosis in each case was based on a com-
plete clinicopathologic workup of the patient before trans-
plantation. For example, the criteria for primary biliary cir-
rhosis (PBC) included positive anti-mitochondrial 
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Table 1. Summary of the Staining Resultsfor the Detection ofS100+ DCs 
Disease No. of cases Intensity Location 
Normal controls 3 0 Rare intra~epithelial DC in large bile ducts. 
Primary biliary cirrhosis 
Stage I-II 5 2+ fntra~epithelial and periductal. 
Stage III-IV 7 0-1+ Portal/septal 
Sclerosing cholangitis 6 0-1+ Periductal * portal/septal 
Secondary biliary cirrhosis 7 1+ Periductal * 
Extrahepatic biliary atresia 7 0-1+ Among hilar inflammation 
Chronic allograft rejection 8 1+ Portal, periductal portal/septal 
Autoimmune 3 0-1+ Areas of piecemeal necrosis 
Chronic active hepatitis 
Viral type B 3 0-1+ Portal, areas of piecemeal necrosis 
Chronic active hepatitis 
NonA, non B 4 0-1+ Portal, areas of piecemeal necrosis 
Chronic active hepatitis 
• Cells usually detected among the intense periductal inflammation around large hilar excretory ducts with disrupted lumenal integrity. 
antibodies at titers greater than 1 :80, combined with a 
consistent clinicopathologic profile. 15- 17 Three normal 
control livers were obtained from organs harvested for 
transplantation, but unused because the potential recipi~ 
ent died or was found to have an inoperable malignancy. 
The tissue was fixed in neutral buffered formalin, em~ 
bedded in paraffin, sectioned at 4 Jl., and routinely stained 
with hematoxylin and eosin (H & E) . Two to five blocks that 
demonstrated active inflammation and ongoing disease 
activity were selected from each specimen. The sections 
selected were stained with an antibody directed at S 100 
protein (Oako, Santa Barbara, CAl for the detection of 
dendritic cells using the avidin~biotin complex method of 
Hsu and coworkers. 18 
Figure lA. Septal bile ductjrom liver witb stage II PBe with early mild inflammatory cell damage. Note the intra~epithelial S100 
positive dendritic cells (arrows, X 160; immunoperoxidasejorS100protein). B: Higher jJOwerojpanelA demonstrating thedendrilic 
cytoplasm ojSlOO positi1!e inlra~epithelial cells. (arrow-heads, X400; immunoperoxidase jor S100 protein). 
-----------------------------------------------
Figure 2. Small septal bile ductfrom liver with early stage PEC 
and poorly formed paraductal granuloma (arrow. X 160; im-
munoperoxidase for 5100 protein)' Note the intra-epithelial 
5100 positive DC (arrow) in an area of early duct damage 
and injlammation (inset, X500; immunoperoxidase for 5100 
protein). 
For the purpose of this study, a dendritic cell was 
defined as a 8100 protein positive cell with a roughly oval 
but irregularly shaped nucleus and a cytoplasm that 
formed flamelike extensions between adjacent cells (den-
dritic). Cells in which the nucleus could not be identified 
or lacked dendritic processes, but were 8100 protein pos-
itive, were enumerated but not considered as true den-
dritic cells. 
The presence, relative number, and location (lobular, 
portal/septal, periductal, intraepithelial, or in areas of ac-
tive piecemeal necrosis) of dendritic cells were separately 
evaluated by four different pathologists and semiquantita-
tively recorded as follows: none; 1 + (0 to 2/hpf); 2+ (2 to 
6/hpf); 3+ (>6/hpf). 
Results 
Identification of S1 00 Positive Cell 
Populations 
Peripheral nerve trunks and adipocytes from hilar sections 
were uniformly 8100 positive in the normal controls and 
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diseased organs and served as internal controls. Occa-
sionally, glandular epithelial cells in the side pouches of 
large hilar excretory ducts were also 8100 positive. The 
remaining parenchymal elements of normal and diseased 
organs were negative. 
Three basic types of inflammatory cells were 8100 
positive but constituted a distinct minority in all the dis-
eased livers. The normal control livers were generally de-
void of inflammatory cells except for rare 8100 positive 
DCs in the epithelium of large septal bile ducts. First, rare 
small round 8100 positive cells resembling inactive lym-
phocytes were seen among the portal inflammation in all 
disorders. A second distinct population of 8100 positive 
cells resembled macrophages with larger oval, angular, 
and clefled reniform nuclei, but without definite dendritic 
cytoplasmic processes. Finally, 8100 positive cells with 
angular clefted nuclei and a dendritic-shaped cytoplasm 
extended between adjacent cells were the focus of this 
study. 
Intensity and Localization of S100 Positive 
Cells in Chronically Diseased Livers 
8100 positive macrophages and DC were most numer-
ous in the "biliary" diseases (eg, primary biliary cirrhosis, 
Figure 3. Disrupted septal bile duct from livers with secondary 
biliary cirrhosis with 5100 positive cell (arrow) in the sur-
rounding inflammation (arrows, X 160; immunoperoxidase 
for 5100 protein). 
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Figure 4. Septal bile duct from liver allograft with chronic re-
jection. Note the periductal SlOO positive cells (arrows) but 
lack of similar cells in the epithelium. (X 160, immunoperoxi-
dase for S 1 00 protein). 
sclerosing cholangitis, secondary biliary cirrhosis, biliary 
atresia, and chronic allograft rejection) when compared 
with all other chronic liver diseases studied. Certain gener-
alizations regarding the presence of 8100 positive cells 
could be made. First, as would be expected, 8100 posi-
tive cells were present only in areas of inflammation. 8ec-
ond, the 8100 positive cells were more numerous in the 
earlier,. precirrhotic phases of the disorders when com-
pared with cirrhotic livers. Finally, the 8100 positive cells 
were limited to the portal/septal, intraductal and periductal 
regions, whereas the lobules were devoid of such cells. 
Biliary Disorders 
The most striking observation in this group of patients 
was the intra-epithelial (ie, inside the basement mem-
brane) localization of 8100 positive DC in areas of the 
livers with stage I to II and II to III PSC. These cells were 
usually localized in septal bile ducts of 100 to 200 Jl. in 
diameter showing evidence of early inflammatory cell 
damage (Figures 1 and 2), which are the initial target 
structures in early PSC.16,17,19 8maller ducts were less 
likely to contain these cells. 8100 positive DC and macro-
phages also were easily identifiable in the periductal re-
gion of portal tracts containing florid duct lesions, both 
within and separate from portal granulomas. It must be 
reemphasized, however, that although the 8100 positive 
cells were seen in the areas of active inflammation, they 
constituted a distinct minority population, 8100 positive 
DC also were seen at the limiting plate in the areas of 
ongoing piecemeal necrosis, but not within the lobule, Liv-
ers with later stage PSC (III and IV), however, were gener-
ally devoid of DCs, 
Livers affected with sclerosing cholangitis also con-
tained occasional intra-epithelial 8100 positive DC, but 
were fewer in number and less prevalent than in livers 
with PSC, Periductal 8100 positive DC and macrophages 
seen among the intense inflammation around disrupted 
large hilar ducts were most characteristic of this disorder. 
Expanded fibrotic portal tracts from the periphery of the 
liver were generally devoid of 8100 positive cells, The 
findings in secondary biliary cirrhosis were most similar to 
those seen in sclerosing cholangitis, but usually without 
intra-epithelial 8100 positive DC (Figure 3). More periph-
eral sections of the livers were devoid of 8100 positive 
cells. Few 8100 positive DC were seen among the hilar 
inflammation in extrahepatic biliary atresia. 
Intra-epithelial DCs were not found with any frequency 
in the allograft livers with chronic rejection; however, 
periductal 81 00 positive DC and macrophages could be 
identified (Figure 4). It should be noted that these organs 
were largely devoid of small bile ducts, which is character-
istic of chronic rejection. 8eptal ducts, similar to the size 
damaged in the early stages of PSC, were inflamed but 
easily identified, and lacked the intraepithelial DCs. 
"Nonbiliary" Diseases 
Livers from patients with autoimmune, viral type Sand 
non-A, non-S chronic active hepatitis were similar to each 
other in respect to the location, intensity, and type of 8100 
positive cells. In general, 8100 positive cells were less nu-
merous in these disorders and did not demonstrate any 
affinity for biliary structures. 8100 positive DC and macro-
phages constituted the majority of identified cells and 
were found at areas of active piecemeal necrosis and 
within the portal tracts/septal, whereas the lobules were 
devoid of such cells. 
A summary of the results for the location and intensity 
of 8100 positive DC in the various disorders studied is 
shown in Table 1. 
Discussion 
The combination of 81 00 protein positivity and cytoplas-
mic dendritic morphology are phenotypic features char-
Figure 5. Schematic of h)pothesis to ex· 
plain the po.l"ihle role of dendritic cells in 
the patho[!,enesis (ifPBC lPN, gamma inter· 
feron; X, target antigens; DG: dendritic 
cells; E, B lymphocyte; PC, plasma cell; HF, 
helperfactors;. HLA-DR. 
acteristic of interdigitating reticulum cells (IDC),2o which 
belong to the dendritic cell famillo and interact closely 
with T lymphocytes. Such cells or their close relatives are 
normally present in areas of antigen processing, such as 
the paracortex of lymph nodes and within the epithelium 
of the skin and mucosal surfaces of the gastrointestinal 
tract.20- 22 The localization of S100 positive DCs in livers 
with chronic inflammatory diseases but not in normal con-
trols or in the end stages of such disorders suggests that 
they may play an important role in the initiation and/or 
propagation of chronic liver disease.8 
The participation of DC in active piecemeal necrosis in 
viral type B and non-A, non-B CAH has been reported 
previouslY,6 and confirmed in this study. Likewise, den-
dritic cells have been detected in other non hepatic 
chronic inflammatory disorders where an autoimmune eti-
ology is suspected.23.24 However, identification of S100 
positive DC in and around the epithelium of damaged sep-
tal bile ducts in early stage PSC is a new observation. 
Furthermore, their presence in areas of early duct dam-
age, but not in normal livers or in the later stages of PSC, 
is circumstantial evidence that they may be intimately in-
volved in disease pathogenesis.8 
It is tempting to speculate that, because S100 positive 
DCs possess the capabilities needed to trigger an effector 
inflammatory cascade (eg, ability to activate unprimed T 
lymphocytes), their role in chronic inflammatory hepatiC 
diseases is crucial. For example, PBC is considered to be 
a "model autoimmune" disorder,15 however, the etiology 
is unknown and pathogenic mechanisms involved in liver 
damage are poorly understood. Sallardini et al25 docu-
mented the aberrant expression of class II MHC antigens 
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by bile duct cells in livers affected by PSC, as is seen for 
epithelial cells of other organs affected by autoimmune 
diseases.26 Parenchymal epithelial cell expression of 
HLA-DR is thought to enable these cells to function as 
APCs and present altered self or exogenous antigens to 
competent T lymphocytes.25.26 However, this hypothesis 
fails to account for the initial stimulus leading to DR ex-
pression by parenchymal epithelial cells. Furthermore, it is 
known that unprimed T lymphocytes require potent APCs 
(eg, dendritic cells) for initial activation,1O·11 but once acti-
vated, primed T cells are able to interact with other, less 
potent, antigen presenting cells, such as macrophages, 
B cells, and perhaps bile duct cells, in generating an im-
mune response.",12 The activated T cells also can pro-
duce gamma interferon, which has been shown to induce 
expression of HLA-DR antigens on bile ducts in vitro.27 
Perhaps the initiation of the inflammation in PSC is trig-
gered by environmental factors, such as solubilized anti-
gen or immune complexes processed by the hepatocytes 
or ductal cells and secreted in the bile.19,28 The exposure 
to antigen may then be followed by dendritic cell recruit-
ment or local proliferation, and interaction with CD4+ lym-
phocytes, which may account for their concentration in 
the periductal regions of livers with PSC (Figure 5).29.30 
Finally, it must be noted that this study suffers from 
key deficiencies. First, although the organs included 
herein were chosen because of active disease, a signifi-
cant proportion were in the mature stages. The exception 
was cases with early stages of PBC (ie, stage I to II or II to 
III), where transplantation was performed because of the 
bone disease associated with this disorder and not the 
hepatic dysfunction. Second, histopathologic studies are 
746 Demetris et al 
AJP April 1989, Vol. 134, NO.4 
by nature static, and investigation of disease progression 
is possible only through multiple samplings from the same 
organ. Alternatively, studying an animal model would be 
helpful.31 Third, the use of antibodies directed at S 1 00 
protein alone, along with dendritic cell morphology, pre-
cludes the identification of S100 negative DCs, such as 
follicular dendritic cells. Such cells may indeed participate 
in chronic inflammatory liver disease, as suggested by 
Bardadin and Desmet.6 However, the dendritic cell family 
is a somewhat heterogenous population and all cells do 
not carry the same antigens, or, if they do, those antigens 
overlap with ones expressed on the more numerous tis-
sue macrophages. Therefore, we chose a simple system 
of identification based on cytoplasmic morphology as out-
lined by S100 protein staining. It should be noted that a 
previous study by Colucci and coworkers32 failed to de-
tect follicular dendritic cells in PBC, which are another dis-
tinct subpopulation of dendritic cells that normally interact 
with B cells in lymphoid follicles. They used an antibody 
directed at C3b receptor,32 one that is not present on in-
terdigitating reticulum cells.20 Last, and most important, 
the documentation of DCs does not prove they are neces-
sary or sufficient for disease occurrenceB Regardless of 
these shortcomings, we believe that this initial study is 
suggestive enough to encourage further investigation into 
the role of DCs in the immunopathology of chronic liver 
disease. 
References 
1. Paronetto F: Cell-mediated immunity in liver disease. Human 
Pathology 1986, 17: 168-178 
2. Paronetto F, Colucci G, Colombo M: Lymphocytes in liver 
disease. Prog Liv Dis 1986, 8: 191-208 
3. Mondelli MU, Manns M, Ferrari C: Does the immune re-
sponse playa role in the pathogenesis of chronic liver dis-
ease. Arch Pathol Lab Med 1988, 112:489-497 
4. Thomas HC, Lever AML: Has immunology become impor-
tant to hepatologists? Prog Liv Dis 1986, 8: 179-189 
5. Popper H, Paronetto F: Problems in the immunology of he-
patic diseases. Hepatogastroenterology 1984, 31 :1-5 
6. Bardadin KA, Desmet VJ: Interdigitating and dendritic reticu-
lum cells in chronic active hepatitis. Histopathology 1985, 8: 
657-667 
7. Voorhis WCV. Hair LS, Steinman RM, Kaplan G: Human den-
dritic cells: Enrichment and characterization from peripheral 
blood. J Exp Med 1982, 155:1172-1187 
8. Poulter LW: Antigen presenting cells in situ: Their identifica-
tion and involvement in immunopathology. Clin Exp Immunol 
1983,53:513-520 
9. Steinman RM: Dendritic cells. Transplantation 1981.31 :151-
155 
10. Steinman RM, Inaba K, Schuler G, Witmer M: Stimulation of 
the immune response: Contributions of dendritic cells, 
Mechanisms of Host Resistance to Infectious Agents, Tu-
mors, and Allografts. Edited by RM Steinman, RJ North. New 
York, Rockefeller University Press, 1986, pp 71-97 
11. Inaba K, Steinman RM: Resting and sensitized T lympho-
cytes exhibit distinct stimulating (antigen presenting cell) re-
quirements for growth and Iymphoklne release. J Exp Med 
1984,160:1717-1735 
12. Inaba K, Steinman RM Protein-specific helper T-Iympho-
cyte formation initiated by dendritic cells. Science 1985, 
229:475-479 
13. Kapsenberg ML, Tennissen MBM, Stiekema FEM, Keizer 
HG: Antigen-presenting cell function of dendritic cells and 
macrophages in proliferative T cell responses to soluble and 
particulate antigens. Eur J Immunol1986, 16:345-350 
14. Knight SC, Krejci J, Malkovsky M. Colizzi V, Gautam A, Ash-
erton GL: The role of dendritic cells in the initiation of immune 
responses to contact sensitizers. I. In vivo exposure to anti-
gen. Celilmmunol1985; 94:427-437 
15. James SP, Hoofnagle JHK. Strober W, Jones FA: Primary 
biliary cirrhosis: A model autoimmune disorder. Ann Int Med 
1983,99:500-512 
16. Rubin E, Schaffner F, Popper H: Primary biliary cirrhosis: 
Chronic non-suppurative destructive cholangitis. Am J Pa-
tho11965, 46:387-407 
17. Portmann B, MacSween RNM: Disease of the intrahepatic 
bile ducts, Pathology of the Liver. 2nd ed. Edited by RNM 
MacSweeen, PP Anthony, RJ Scheuer. New York, Churchill 
Livingstone, 1987, pp424-453 
18. Hsu SM, Raine L, Fanger H: The use of avidin-biotin-peroxl-
dase complex (ABC) in immunoperoxidase techniques: A 
comparison between ABC and unlabeled antibody (PAP) 
procedures. J Histochem Cytochem 1981, 29:577 -580 
19. Sherlock S: Primary biliary Cirrhosis. Diseases of the Liver. 
6th ed. Edited by L Schiff, ER Schiff. Philadelphia, JB lippin-
cott Co, Philadelphia, 1987, pp 979-1000 
20. Wood GS, Tumer RR, Shiurba RA, Eng L, Wamke RA: Hu-
man dendritic cells and macro phages: In situ immunopheno-
typic definition of subsets that exhibit specific morphologic 
and microenvironmental characteristics. Am J Pathol 1985, 
11973-82 
21. Franklin WA, Mason DY, Pulfero K, Falini B, Bliss F, Gaiter 
KC, Stein H, Clarke LC, McGee JOD: Immunohistochemical 
analysis of human mononuclear phagocytes and dendritic 
cells by using monoclonal antibodies. Lab Invest 1986, 54: 
322-335 
22. Hancock WW, Afkins RC: Immunohistological analysis of the 
cell surface antigens of human dendritic cells using mono-
clonal antibodies. Transplant Proceed 1984, 16:363-367 
23. Poulter LW, Duke 0, Hobbs S, Janossy G, Panayi G, Sey-
mour G: The involvement of interdigitating (antigen present-
ing) cells in the pathogenesis of rheumatoid arthritis. Clin 
Exp Immunol1983, 51 :247-254 
24. Wilders MM, Drexhage HA, Koje M. Verspaget HW, Meuwis-
sen SG: Veiled cells in chronic idiopathic inflammatory bowel 
disease. Clin Exp Immunol1984, 55:377-387 
25. Ballardini G, Minakian R, Bianchi FB, Pisi E, Doniach D, Bo-
tazzo GF: Aberrant expression of HLA-DR antigens on bile 
duct epithelium in primary biliary cirrhosis relevance to 
pathogenesis. Lancet 1984, 3: 1 009-1 013 
26. Battazzo GF, Pujol-Borrell R, Hanafusa T, Feldman M: Role 
of aberrant HLA-DR expression and antigen presentation 
in induction of endocrine autoimmune. Lancet 1983, 2: 
1115-1119 
27. Demetris AJ, Markus B, Saidman S, Fung J, Makowka L, 
Duquesnoy R, Starzl TE: Establishment of primary cultures 
of human biliary epithelium and induction of class II major 
histocompatibility complex antigens by interferon gamma. 
Transplant Proc 1988, 20:728-730 
28. Nagura H, Smith PO, Nakane PK, Brown WR: IgA in human 
bile and liver. J Immunol1981, 126:587-595 
29. Van Den Oord JJ, Fevery J, De Groote J, Demest VJ: Immu-
nohistochemical characterization of inflammatory infiltrates 
in primary biliary cirrhosis. Liver 1984, 14264-274 
Dendritic Cells in PBC 747 
AJP April 1989, Vol. 134, No.4 
30. Si L, Whiteside TL, Schade RR, Starzl TE, Van Thiel DH T-
lymphocyte subsets in liver tissues of patients with primary 
biliary cirrhosis (PBG), patients with sclerosing cholangitis 
(PSG), and normal controls. J Clin Immunol1984, 4:262-272 
31. Tison V, Callea F, Morisi C, Mancini AM, Desmet VJ: Sponta-
neous "primary biliary cirrhosis" in rabbits. Liver 1982, 2: 
152-161 
32. Colucci G, Schaffner F, Paronetto F: In situ characterization 
of the cell-surface antigens of the mononuclear infiltrate and 
bile duct epithelium in primary biliary cirrhosis. Clin Immunol 
Immunopathol 1986, 41 :35-42 
Acknowledgment 
The authors thank Mary Ann Mient for preparation of the manu-
script and Judy Burnham for the perforrnance of the immunohis-
tologic stains. 
